← Back to Search

Caring Contacts for Suicide Prevention (CARE Trial)

N/A
Waitlist Available
Led By Lonnie A Nelson, PhD
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be 18 years or older
Be older than 18 years old
Must not have
Cognitively unable and willing to independently provide written informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 and 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate how well a low-cost, sustainable intervention called Caring Contacts works to prevent suicide among American Indians and Alaska Natives aged 18 and older.

Who is the study for?
This trial is for American Indian or Alaska Native adults who are at least 18 years old, can speak and read English, have had suicidal thoughts or an attempt within the past year, and are willing to receive messages by text, email, or mail. It's not for those unable to consent independently.
What is being tested?
The study tests 'Caring Contacts', a suicide prevention approach that involves sending supportive messages to individuals at risk. The effectiveness of this low-cost intervention will be evaluated across four tribal communities.
What are the potential side effects?
Since 'Caring Contacts' involves sending caring messages without medical treatment, there are no direct physical side effects expected from the intervention itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to understand or sign the consent form by myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Suicidal Ideation Questionnaire (SIQ)
Suicide Attempt and Self-Injury Count (SASI-Count)
Suicide-related hospitalizations
Secondary study objectives
Interpersonal Needs Questionnaire (INQ) Thwarted Belongingness subscale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care + Caring Contacts messagesExperimental Treatment2 Interventions
Usual care services plus caring contacts messages
Group II: Usual CareActive Control1 Intervention
Usual care services provided in that community following identification of suicidal ideation or behavior.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual Care
1990
Completed Phase 4
~7700

Find a Location

Who is running the clinical trial?

Washington State UniversityLead Sponsor
106 Previous Clinical Trials
56,817 Total Patients Enrolled
University of WashingtonOTHER
1,815 Previous Clinical Trials
1,912,337 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,254 Total Patients Enrolled

Media Library

Caring Contacts Messages Clinical Trial Eligibility Overview. Trial Name: NCT02825771 — N/A
Suicidal Thoughts Research Study Groups: Usual Care + Caring Contacts messages, Usual Care
Suicidal Thoughts Clinical Trial 2023: Caring Contacts Messages Highlights & Side Effects. Trial Name: NCT02825771 — N/A
Caring Contacts Messages 2023 Treatment Timeline for Medical Study. Trial Name: NCT02825771 — N/A
~96 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top